查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
一氧化氮吸入输送系统市场- 全球产业分析，规模，占有率，成长，趋势，及预测，2022-2031年
市场调查报告书
商品编码
1229624

一氧化氮吸入输送系统市场- 全球产业分析，规模，占有率，成长，趋势，及预测，2022-2031年

Inhaled Nitric Oxide Delivery System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 182 Pages | 商品交期: 2-10个工作天内

价格

本报告以2022年为基准年，以2031年为预测年，提供从2017年到2031年的一氧化氮吸入输送系统的世界市场收益。还有从2022年到2031年的一氧化氮吸入输送系统的全球市场的年复合成长率(CAGR%)。

本报告经由广泛研究製作。在一手调查中，分析师对主要意见领袖、产业领袖和舆论製造者进行访谈，进行大部分的研究工作。在二次调查中，透过参考各大公司的产品资料、年报、新闻稿、相关文件等，掌握一氧化氮吸入输送系统市场。

本报告深入研究全球一氧化氮吸入输送系统市场竞争情形。识别一氧化氮吸入输送系统的全球市场开展事业的主要企业，进行各企业的各种属性侧写。介绍企业概要，财务状况，最近的开拓，SWOT，一氧化氮吸入输送系统的全球市场中企业的属性。

目录

第1章 序文

  • 市场定义和范围
  • 市场区隔
  • 主要的调查目的
  • 调查亮点

第2章 前提条件与调查手法

第3章 摘要整理:一氧化氮吸入输送系统的全球市场

第4章 市场概要

  • 简介
    • 市场区隔定义
  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 一氧化氮吸入输送系统的全球市场的分析与预测，2017-2031年
    • 市场收益预测

第5章 关键见解

  • 不仅是成人，概观儿童的iNO的应用。
  • 技术的进步
  • 关于全球疾病的得病率和发生率，主要国家
  • COVID-19影响度分析

第6章 一氧化氮吸入输送系统的全球市场分析、预测:各类型

  • 简介和定义
  • 主要的发现、发展
  • 市场价值预测:各类型，2017年～2031年
    • 儿童
    • 成人
  • 市场魅力分析:各类型

第7章 一氧化氮吸入输送系统的全球市场分析、预测:各用途

  • 简介和定义
  • 主要的发现、发展
  • 市场价值预测:各应用领域，2017-2031年
    • 关于低氧性呼吸不全的处理
    • 急性血管反应性实验(Acute Vasoreactivity Testing
    • 关于肺高血压(PH)的治疗
    • 其他
  • 市场魅力分析:各应用领域

第8章 一氧化氮吸入输送系统的全球市场分析、预测:各终端用户

  • 简介和定义
  • 主要的发现、发展
  • 市场价值预测:各终端用户，2017年～2031年
    • 医院
    • 门诊病人手术中心
    • 其他
  • 市场魅力分析:各终端用户

第9章 一氧化氮吸入输送系统的全球市场分析、预测:各地区

  • 主要调查结果
  • 市场价值预测:各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美
    • 中东
  • 市场魅力分析:各地区

第10章 北美的一氧化氮吸入输送系统的市场分析与预测

  • 简介
    • 主要调查结果
  • 市场价值预测:各类型，2017年～2031年
    • 儿童
    • 成人
  • 市场价值预测:各应用领域，2017-2031年
    • 关于低氧性呼吸不全的处理
    • 急性血管反应性实验(Acute Vasoreactivity Testing
    • 关于肺高血压(PH)的治疗
    • 其他
  • 市场价值预测:各终端用户，2017年～2031年
    • 医院
    • 门诊病人手术中心
    • 其他
  • 市场价值预测:各国，2017-2031年
    • 美国
    • 加拿大
  • 市场魅力度分析
    • 各类型
    • 各应用领域
    • 各终端用户
    • 各国

第11章 欧洲的一氧化氮吸入输送系统市场分析与预测

  • 简介
    • 主要调查结果
  • 市场价值预测:各类型，2017年～2031年
    • 儿童
    • 成人
  • 市场价值预测:各应用领域，2017-2031年
    • 关于低氧性呼吸不全的处理
    • 急性血管反应性实验(Acute Vasoreactivity Testing
    • 关于肺高血压(PH)的治疗
    • 其他
  • 市场价值预测:各终端用户，2017年～2031年
    • 医院
    • 门诊病人手术中心
    • 其他
  • 市场价值预测:各国和各地，2017-2031年
    • 德国
    • U.K.
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲
  • 市场魅力度分析
    • 各类型
    • 各应用领域
    • 各终端用户
    • 各国和各地

第12章 亚太地区的一氧化氮吸入输送系统市场分析与预测

  • 简介
    • 主要调查结果
  • 市场价值预测:各类型，2017年～2031年
    • 儿童
    • 成人
  • 市场价值预测:各应用领域，2017-2031年
    • 关于低氧性呼吸不全的处理
    • 急性血管反应性实验(Acute Vasoreactivity Testing
    • 关于肺高血压(PH)的治疗
    • 其他
  • 市场价值预测:各终端用户，2017年～2031年
    • 医院
    • 门诊病人手术中心
    • 其他
  • 市场价值预测:各国和各地，2017-2031年
    • 中国
    • 日本
    • 印度
    • 澳洲、纽西兰
    • 其他亚太地区
  • 市场魅力度分析
    • 各类型
    • 各应用领域
    • 各终端用户
    • 各国和各地

第13章 南美一氧化氮吸入输送系统市场分析与预测

  • 简介
    • 主要调查结果
  • 市场价值预测:各类型，2017年～2031年
    • 儿童
    • 成人
  • 市场价值预测:各应用领域，2017-2031年
    • 关于低氧性呼吸不全的处理
    • 急性血管反应性实验(Acute Vasoreactivity Testing
    • 关于肺高血压(PH)的治疗
    • 其他
  • 市场价值预测:各终端用户，2017年～2031年
    • 医院
    • 门诊病人手术中心
    • 其他
  • 市场价值预测:各国和各地，2017-2031年
    • 巴西
    • 墨西哥
    • 其他南美国家地区
  • 市场魅力度分析
    • 各类型
    • 各应用领域
    • 各终端用户
    • 各国和各地

第14章 中东的一氧化氮吸入输送系统市场分析与预测

  • 简介
    • 主要调查结果
  • 市场价值预测:各类型，2017年～2031年
    • 儿童
    • 成人
  • 市场价值预测:各应用领域，2017-2031年
    • 关于低氧性呼吸不全的处理
    • 急性血管反应性实验(Acute Vasoreactivity Testing
    • 关于肺高血压(PH)的治疗
    • 其他
  • 市场价值预测:各终端用户，2017年～2031年
    • 医院
    • 门诊病人手术中心
    • 其他
  • 市场价值预测:各国和各地，2017-2031年
    • GCC各国
    • 南非
    • 其他中东、南非地区
  • 市场魅力度分析
    • 各类型
    • 各应用领域
    • 各终端用户
    • 各国和各地

第15章 竞争情形

  • 市场企业-竞争矩阵(各等级，各企业规模)
  • 市场占有率分析:各企业，2021年
  • 企业简介
    • Mallinckrodt
    • Santair AE
    • VERO Biotech
    • Linde plc
    • Beyond Air, Inc.
    • SLE
    • Bellerophon Therapeutics
    • Air Liquide Healthcare
    • International Biomedical
    • Circassia Pharmaceuticals
Product Code: TMRGL85332

The report provides revenue of the global inhaled nitric oxide delivery system market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global inhaled nitric oxide delivery system market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the inhaled nitric oxide delivery system market.

The report delves into the competitive landscape of the global inhaled nitric oxide delivery system market. Key players operating in the global inhaled nitric oxide delivery system market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global inhaled nitric oxide delivery system market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Inhaled Nitric Oxide Delivery System Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Overview of applications of iNO in pediatric as well as in adults
  • 5.2. Technological Advancements
  • 5.3. Disease prevalence and incidence globally with key countries
  • 5.4. Covid-19 Impact Analysis

6. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Pediatric
    • 6.3.2. Adult
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Hypoxemic Respiratory Failure Treatment
    • 7.3.2. Acute Vasoreactivity Testing
    • 7.3.3. Pulmonary Hypertension (PH) Treatment
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Inhaled Nitric Oxide Delivery System Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2017-2031
    • 10.2.1. Pediatric
    • 10.2.2. Adult
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Hypoxemic Respiratory Failure Treatment
    • 10.3.2. Acute Vasoreactivity Testing
    • 10.3.3. Pulmonary Hypertension (PH) Treatment
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Ambulatory Surgical Centers
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Inhaled Nitric Oxide Delivery System Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2031
    • 11.2.1. Pediatric
    • 11.2.2. Adult
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Hypoxemic Respiratory Failure Treatment
    • 11.3.2. Acute Vasoreactivity Testing
    • 11.3.3. Pulmonary Hypertension (PH) Treatment
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Ambulatory Surgical Centers
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Inhaled Nitric Oxide Delivery System Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Pediatric
    • 12.2.2. Adult
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Hypoxemic Respiratory Failure Treatment
    • 12.3.2. Acute Vasoreactivity Testing
    • 12.3.3. Pulmonary Hypertension (PH) Treatment
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Ambulatory Surgical Centers
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Inhaled Nitric Oxide Delivery System Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Pediatric
    • 13.2.2. Adult
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Hypoxemic Respiratory Failure Treatment
    • 13.3.2. Acute Vasoreactivity Testing
    • 13.3.3. Pulmonary Hypertension (PH) Treatment
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Ambulatory Surgical Centers
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East Inhaled Nitric Oxide Delivery System Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2031
    • 14.2.1. Pediatric
    • 14.2.2. Adult
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Hypoxemic Respiratory Failure Treatment
    • 14.3.2. Acute Vasoreactivity Testing
    • 14.3.3. Pulmonary Hypertension (PH) Treatment
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Ambulatory Surgical Centers
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & South Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. Mallinckrodt
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Santair AE
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. VERO Biotech
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Linde plc
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Beyond Air, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. SLE
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Bellerophon Therapeutics
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Air Liquide Healthcare
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. International Biomedical
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Circassia Pharmaceuticals
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments

List of Tables

  • Table 01: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 07: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 11: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 15: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 19: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Material 2017-2031
  • Table 20: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 23: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Inhaled Nitric Oxide Delivery System Market Value Share, by Type, 2021
  • Figure 03: Global Inhaled Nitric Oxide Delivery System Market Value Share, by Application, 2021
  • Figure 04: Global Inhaled Nitric Oxide Delivery System Market Value Share, by End-user, 2021
  • Figure 05: Global Inhaled Nitric Oxide Delivery System Market Value Share, by Region, 2021
  • Figure 06: Global Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 07: Global Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 08: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn), by Pediatric, 2017-2031
  • Figure 09: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn), by Adult, 2017-2031
  • Figure 10: Global Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 11: Global Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 12: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Hypoxemic Respiratory Failure Treatment, 2017-2031
  • Figure 13: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Acute Vasoreactivity Testing, 2017-2031
  • Figure 14: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Pulmonary Hypertension (PH) Treatment, 2017-2031
  • Figure 15: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 16: Global Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user 2021 and 2031
  • Figure 17: Global Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user 2022-2031
  • Figure 18: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 19: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017-2031
  • Figure 20: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 21: Global Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 22: Global Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 23: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 24: North America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 25: North America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Country, 2022-2031 
  • Figure 26: North America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 27: North America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type 2022-2031
  • Figure 28: North America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 29: North America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application 2022-2031
  • Figure 30: North America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 31: North America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 32: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 33: Europe Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 34: Europe Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 35: Europe Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 36: Europe Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 37: Europe Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application 2021 and 2031
  • Figure 38: Europe Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application 2022-2031
  • Figure 39: Europe Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 40: Europe Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 41: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 43: Asia Pacific Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 44: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 45: Asia Pacific Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 46: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 47: Asia Pacific Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 48: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 49: Asia Pacific Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 50: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 51: Latin America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 52: Latin America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 53: Latin America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 54: Latin America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 55: Latin America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 56: Latin America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 57: Latin America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 58: Latin America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 59: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 60: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 61: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 62: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 63: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 64: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 65: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 66: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 67: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 68: Company Share Analysis